InnoCare Pharma Limited (HKG:9969)
Hong Kong · Delayed Price · Currency is HKD 12.14
-0.11 (-0.90%)
Jan 21, 2026, 3:05 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 23.8 billion as of January 20, 2026. Its market cap has increased by 99.67% in one year.
Market Cap
23.80B
Enterprise Value
17.96B
Revenue
1.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
12.14
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 23.80B, an increase of 93.81%. That is a compound annual growth rate of 12.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 24.06B | 1.57% |
| Dec 31, 2025 | 23.69B | 93.83% |
| Dec 31, 2024 | 12.22B | -6.80% |
| Dec 29, 2023 | 13.11B | -44.09% |
| Dec 30, 2022 | 23.45B | 11.18% |
| Dec 31, 2021 | 21.09B | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |